Alembic Pharma achieves USFDA final approval for Oseltamivir Oral Suspension, a Tamiflu equivalent, enhancing its market presence.
SENSEX 77,100.47
+ 109.25
NIFTY 24,056.00
+ 34.35
CRUDEOIL 6,809.00
Alembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for…
Alembic Pharmaceuticals receives USFDA approval for generic Dapsone gel, a topical acne treatment equivalent to Aczone.
Alembic Pharmaceuticals receives USFDA approval for generic levothyroxine sodium tablets, a key treatment for hypothyroidism.
Alembic Pharma receives USFDA tentative approval for 45 mg generic Binimetinib tablets, targeting cancer treatment market.
Zydus receives USFDA approval for a surgical imaging drug, Indocyanine Green, with a 180-day exclusivity window for marketing.
Glenmark launches generic vancomycin hydrochloride injection in the US, enhancing its injectable portfolio and treatment options.
